Advertisement
Kymera Therapeutics, Inc. (KYMR)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
As of 01:16PM EST. Market open.
| Previous Close | 49.86 |
| Open | 49.91 |
| Bid | 49.97 x 100 |
| Ask | 50.56 x 100 |
| Day's Range | 49.39 - 51.13 |
| 52 Week Range | 13.85 - 53.27 |
| Volume | |
| Avg. Volume | 412,521 |
| Market Cap | 3.258B |
| Beta (5Y Monthly) | 2.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.34 |
| Earnings Date | Oct 31, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 57.44 |
GlobeNewswireKymera Therapeutics to Participate in Upcoming November Investor Conferences
WATERTOWN, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events: Guggenheim Inaugural Healthcare Innovation Conference in Boston, MA on November 12 at 10:00 a.m. ET;J.P. Morgan Equity Opportunities Forum in Miami, FL on Novem
Simply Wall St.Analysts Have Made A Financial Statement On Kymera Therapeutics, Inc.'s (NASDAQ:KYMR) Third-Quarter Report
Last week, you might have seen that Kymera Therapeutics, Inc. ( NASDAQ:KYMR ) released its quarterly result to the...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.